For young adults, the coupling strength between the subthalamic nucleus (STN) and median cingulate cortex may be involved in the association between resiliency and alcohol/drug use.

Cholestyramine and activated charcoal can be used to virtually eliminate the long half-life oral investigational multiple sclerosis drug, teriflunomide, from the plasma in 11 days.

People with MS frequently reported having both episodic and chronic migraines, with Hispanic MS patients experiencing significantly more chronic migraines.

In clinical trials, treatment of patients with the oral disease-modifying therapy, teriflunomide, for relapsing forms of multiple sclerosis can result in hair loss/thinning, but this side effect is generally manageable.

For patients taking statins for prevention of cardiovascular disease (CVD), extended care with nurse-led cardiovascular risk-factor counseling improves statin adherence and reduces anxiety, with improvements seen in low-density lipoprotein cholesterol for primary prevention patients.

Differences in white matter integrity in the brain account for some of the variation in general intelligence in elderly individuals, with their effect mediated by information-processing speed.

The annual meeting of the American Association of Clinical Endocrinologists (AACE) was held from May 23 to 27 in Philadelphia and attracted approximately 17,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in endocrinology. The conference highlighted recent advances in endocrinology, diabetes, and metabolism, with presentations focusing on diabetes, metabolic dysfunction, thyroid disorders, osteoporosis, and obesity.

For infants with neonatal hypoxic-ischemic encephalopathy, undergoing whole-body hypothermia results in lower mortality rates as well as a nonsignificant reduction in the combined end point of death or an IQ score of less than 70 at age 6 to 7 years, compared with usual care.

For patients with community-acquired pneumonia without preexisting diabetes, serum glucose levels at admission are predictive of death at 28 and 90 days

In stable kidney transplant recipients, kidney function, as determined by estimated glomerular filtration rate (eGFR), is independently associated with cardiovascular (CVD) events and death.